Virdante Pharmaceuticals

About:

Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.

Website: http://www.virdante.com

Top Investors: Biogen, Venrock, OUP (Osage University Partners), Clarus Ventures, Thomas, McNerney & Partners

Description:

Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its name to Virdante Pharmaceuticals, Inc. in April, 2008. The company was founded in 2007 and is based in Cambridge, Massachusetts.